Ardelyx reported $14.82M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Abbott USD 5.27B 834M Jun/2025
Amgen USD 3.01B 406M Jun/2025
Ardelyx USD 14.82M 3.44M Jun/2025
Corcept Therapeutics USD 3.43M 1.03M Jun/2025
Life Technologies 15.38M 15.38M Jun/2025
Sanofi EUR 2.99B 721M Jun/2025
TG Therapeutics USD 18.94M 3.4M Jun/2025
United Therapeutics USD 175.2M 102.3M Jun/2025